| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785025 | Advances in Radiation Oncology | 2017 | 30 Pages |
Abstract
In addition to providing an opportunity for long-term disease control and functional eye preservation, PRT does not appear to be associated with unexpected late visual, endocrine, or QOL effects in this cohort of patients with RB.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kent W. MD PhD, Beow Y. ScD, Paul MD, Aaron MD, Madhusmita MD MPH, Roshan V. MD, Shannon M. MD, Yen-Lin MD, Nancy J. MD, Torunn I. MD MCH, Suzanne K. MD, John E. MD, Eric MD ScD, Michelle MD MPH, Karen PhD, Dawn MD, Gena MD, Jessica MD, Helen A. MD,